Compass Pathways 2025 Financial Review
Company Overview Compass Pathways plc is a biotechnology company developing COMP360, an investigational synthetic psilocybin therapy for mental health conditions...
7 articles, transcripts, and reports
Company Overview Compass Pathways plc is a biotechnology company developing COMP360, an investigational synthetic psilocybin therapy for mental health conditions...
COMPASS Pathways plc (CMPS) reported Q4 2025 GAAP earnings of -$1.00 per share.
COMPASS Pathways PLC (NASDAQ: CMPS) Q2 2022 Earnings Conference
COMPASS Pathways PLC (NASDAQ: CMPS) Q4 2021 Earnings Conference
COMPASS Pathways PLC (NASDAQ: CMPS) Q2 2021 Earnings Conference
COMPASS Pathways PLC (NASDAQ: CMPS) Q1 2021 Earnings Conference
COMPASS Pathways PLC (NASDAQ: CMPS) Q4 2020 Earnings Conference